TRNX

TRNX Company Financials

$16.9
*  
0.30
  negative  
1.81%
Get TRNX Alerts
*Delayed - data as of May 23, 2013 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

 Save stocks for next time


Annual Income Statement (values in 000's)

Period Ending: Trend 12/30/2012 1/1/2012 1/2/2011 12/27/2009
Total Revenue
$277,520 $261,191 $227,378 $201,462
Cost of Revenue
$81,918 $74,882 $63,437 $54,859
Gross Profit
$195,602 $186,309 $163,941 $146,603
Operating Expenses
Research and Development
$22,524 $19,839 $17,896 $18,120
Sales, General and Admin.
$170,447 $161,448 $149,175 $136,420
Non-Recurring Items
$19,244 $892 $306 $1,864
Other Operating Items
$11,721 $11,282 $11,492 $15,173
Operating Income
($28,334) ($7,152) ($14,928) ($24,974)
Add'l income/expense items
($612) ($27,402) ($7,897) ($25,208)
Earnings Before Interest and Tax
($28,946) ($34,554) ($22,825) ($50,182)
Interest Expense
$3,733 $4,326 $21,805 $19,917
Earnings Before Tax
($32,679) ($38,880) ($44,630) ($70,099)
Income Tax
($10,935) ($8,424) ($5,121) ($14,413)
Minority Interest
$0 $0 $695 $1,067
Equity Earnings/Loss Unconsolidated Subsidiary
$0 $0 $0 $0
Net Income-Cont. Operations
($22,337) ($59,931) ($38,814) ($54,619)
Net Income
($21,744) ($30,456) ($38,814) ($54,619)
Net Income Applicable to Common Shareholders
($21,744) ($30,456) ($39,493) ($55,746)

See also: Company Financials data entry page